CMTx Biotech
James Keane is the Co-Founder & COO at CMTx Biotech. Previously, James was Advisor at MobileWare. James holds an MBA in Finance from Stony Brook University.
This person is not in any offices
CMTx Biotech
CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).